According to a report by Intel Market Research, the global Dupilumab Drug Market was valued at USD 16,960 million in 2024 and is projected to reach USD 34,940 million by 2032, registering a CAGR of 11.2% during the forecast period. The market is experiencing substantial growth driven by the increasing prevalence of chronic inflammatory diseases, expanding regulatory approvals, growing adoption...